Get notified when GEVO files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: GEVO Gevo, Inc. 8-K

Gevo appoints former ADM Chief Science Officer Todd Werpy to Board of Directors

Filed July 16, 2026 · Period ending July 13, 2026 · ~1 min read

Key Changes

  • medium

    Todd Werpy, Ph.D., appointed as independent Class II director effective August 20, 2026, with term expiring at 2027 annual meeting. Werpy brings 30+ years in sustainable technologies, R&D, and manufacturing operations.

    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
  • medium

    Werpy most recently served as Chief Science Officer and Executive Committee member at ADM, where he built technology pipelines generating enterprise value and led modernization programs involving automation and advanced process controls.

    Exhibit 99.1 view on EDGAR →
  • medium

    Werpy holds 36 U.S. patents and over 100 patents globally, with expertise spanning biotechnology, catalysis, process engineering, and commercialization of bio-based technologies. Recipient of American Chemical Society's Green Chemistry Award.

    Exhibit 99.1 view on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ISNR 10-Q) is open in full — no account needed.

Partner

Trade GEVO commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 20, 2026 · How we verify